Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 USD | +10.20% |
|
+438.92% | +80.00% |
Valuation
Fiscal Period: September | 2022 | 2023 |
---|---|---|
Capitalization 1 | 11.84 | 2.605 |
Enterprise Value (EV) 1 | 11.86 | 2.625 |
P/E ratio | -255 x | -70.1 x |
Yield | - | - |
Capitalization / Revenue | - | - |
EV / Revenue | - | - |
EV / EBITDA | - | - |
EV / FCF | - | - |
FCF Yield | - | - |
Price to Book | -216 x | -64 x |
Nbr of stocks (in thousands) | 5,920 | 5,920 |
Reference price 2 | 2.000 | 0.4400 |
Announcement Date | 02/12/22 | 02/01/24 |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales | - | - | - | - |
EBITDA | - | - | - | - |
EBIT 1 | -0.0231 | -0.0322 | -0.0464 | -0.0376 |
Operating Margin | - | - | - | - |
Earnings before Tax (EBT) 1 | -0.0231 | -0.0322 | -0.0464 | -0.0376 |
Net income 1 | -0.0231 | -0.0322 | -0.0464 | -0.0371 |
Net margin | - | - | - | - |
EPS | - | -0.008892 | -0.007841 | -0.006273 |
Free Cash Flow | - | -0.005695 | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 12/11/20 | 15/12/21 | 02/12/22 | 02/01/24 |
Balance Sheet Analysis
Fiscal Period: September | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 0 | - | 0.02 | 0.02 |
Net Cash position 1 | - | 0.01 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - |
Free Cash Flow | - | -0.01 | - | - |
ROE (net income / shareholders' equity) | - | 659% | 147% | 78.7% |
ROA (Net income/ Total Assets) | - | -99.3% | -205% | - |
Assets 1 | - | 0.0324 | 0.0226 | - |
Book Value Per Share 2 | -0 | -0 | -0.0100 | -0.0100 |
Cash Flow per Share | - | 0 | - | 0 |
Capex | - | - | - | - |
Capex / Sales | - | - | - | - |
Announcement Date | 12/11/20 | 15/12/21 | 02/12/22 | 02/01/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+80.00% | 1.6M | |
+26.15% | 75.76B | |
-2.46% | 23.95B | |
+14.23% | 8.7B | |
+1.47% | 8.29B | |
-32.92% | 6.7B | |
+18.62% | 5.38B | |
+1.10% | 4.08B | |
-9.24% | 3.79B | |
-10.20% | 3.3B |
- Stock Market
- Equities
- MCLE Stock
- Financials Medicale Corp.